Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications.
about
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trialMethods for the development and assessment of atrial fibrillation and heart failure dog modelsXimelagatran for stroke prevention in atrial fibrillation.Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.Atrial fibrillation and heart failure: cause or effect?Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.An altered expression of genes involved in the regulation of ion channels in atrial myocytes is correlated with the risk of atrial fibrillation in patients with heart failure.Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.Usefulness of the WCD in patients with suspected tachymyopathy.Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure.
P2860
Q33711829-39EA8A1B-8EDB-4202-AFAC-5E8D89901E5DQ34626361-05363C07-63C6-4590-AE60-C91DF0B44CD8Q36077270-E36EF27E-37E5-4440-A3C8-8043C88BD2D1Q36216784-701B8EF9-03E2-4E45-A89F-D44DFC8DE90FQ37441193-157564E6-DFFC-4D21-9408-F1188D04D9F1Q38116784-0B854CC2-6858-46D4-8DE3-964F54233967Q38254552-C19E1B62-1716-4F52-A239-E90AC071179AQ38853630-C9BEFE6F-3F94-486F-8AD3-0FCF43051D3FQ39433065-780B15FE-4CF9-40B8-BC50-1AB9D88F9425Q44699178-C2C21D99-B74C-4DB4-96E9-39D3005618B5Q49376064-E5E759D8-E55B-4A1F-97BB-909A923ECCA8Q50077869-B9FDBD64-F40F-4FFB-AAB8-823AA37252AB
P2860
Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Heart failure complicated by a ...... and therapeutic implications.
@ast
Heart failure complicated by a ...... and therapeutic implications.
@en
type
label
Heart failure complicated by a ...... and therapeutic implications.
@ast
Heart failure complicated by a ...... and therapeutic implications.
@en
prefLabel
Heart failure complicated by a ...... and therapeutic implications.
@ast
Heart failure complicated by a ...... and therapeutic implications.
@en
P2860
P1476
Heart failure complicated by a ...... and therapeutic implications.
@en
P2093
Gerian C Grönefeld
Stefan H Hohnloser
P2860
P304
P356
10.1177/107424840300800203
P577
2003-06-01T00:00:00Z